These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31601845)

  • 1. In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria.
    Blaskovich MAT; Elliott AG; Kavanagh AM; Ramu S; Cooper MA
    Sci Rep; 2019 Oct; 9(1):14658. PubMed ID: 31601845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
    Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
    BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of benzoyl peroxide in the new treatment paradigm for acne.
    Kircik LH
    J Drugs Dermatol; 2013 Jun; 12(6):s73-6. PubMed ID: 23839205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact and importance of resistance.
    Tanghetti E
    Cutis; 2007 Jul; 80(1 Suppl):5-9. PubMed ID: 17824580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in understanding
    Platsidaki E; Dessinioti C
    F1000Res; 2018; 7():. PubMed ID: 30613388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of oral antibiotics in treating acne vulgaris: a new approach.
    Farrah G; Tan E
    Dermatol Ther; 2016 Sep; 29(5):377-384. PubMed ID: 27306750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating acne with antibiotic-resistant bacterial colonization.
    Tzellos T; Zampeli V; Makrantonaki E; Zouboulis CC
    Expert Opin Pharmacother; 2011 Jun; 12(8):1233-47. PubMed ID: 21355786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
    Leyden JJ; Del Rosso JQ; Webster GF
    Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance of microbial strains isolated from Korean acne patients.
    Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
    J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
    Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic-resistant acne: getting under the skin.
    Sinha M; Sadhasivam S; Bhattacharyya A; Jain S; Ghosh S; Arndt KA; Dover JS; Sengupta S
    Semin Cutan Med Surg; 2016 Jun; 35(2):62-7. PubMed ID: 27416310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations.
    Dessinioti C; Katsambas A
    Yale J Biol Med; 2022 Dec; 95(4):429-443. PubMed ID: 36568833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers.
    Eady AE; Cove JH; Layton AM
    Am J Clin Dermatol; 2003; 4(12):813-31. PubMed ID: 14640775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris.
    Nakase K; Yoshida A; Saita H; Hayashi N; Nishijima S; Nakaminami H; Noguchi N
    J Dermatol; 2019 Sep; 46(9):782-786. PubMed ID: 31254314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics.
    Chien AL; Tsai J; Leung S; Mongodin EF; Nelson AM; Kang S; Garza LA
    JAMA Dermatol; 2019 Apr; 155(4):425-434. PubMed ID: 30758497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
    Sagransky M; Yentzer BA; Feldman SR
    Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.